Last reviewed · How we verify
NCT03806244: PELVINAV
Feasibility of Stereotactic Navigation in Laparoscopic Surgery for Colorectal Cancer
NA trial testing Intraoperative acquisition (robotic c-Arm) of images in Colorectal Cancer in 12 participants. Terminated before completion.
10 October 2022
Quick facts
| Lead sponsor | IHU Strasbourg |
|---|---|
| Phase | NA |
| Status | Terminated |
| Study type | INTERVENTIONAL |
| Allocation | non randomized |
| Design | parallel |
| Masking | none |
| Primary purpose | prevention |
| Enrollment | 12 |
| Start date | 17 July 2019 |
| Primary completion | 10 October 2022 |
| Estimated completion | 10 October 2022 |
| Sites | 1 location across France |
Drugs / interventions tested
- Intraoperative acquisition (robotic c-Arm) of images
Conditions studied
- Colorectal Cancer — all drugs for Colorectal Cancer →
Sponsor
IHU Strasbourg — full company profile →
Who can join
18 and older, any sex, with Colorectal Cancer. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
To evaluate the feasibility and precision of stereotaxic navigation in laparoscopic surgery for colorectal cancer.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT03806244
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Colorectal Cancer
Currently open trials in the same condition.
- NCT07152821 — Botensilimab + Balstilimab vs Best Supportive Care as Therapy in Chemo-refractory, Unresectable, Colorectal Adenocarcino · Phase 3 · recruiting
- NCT07353645 — KRAS Neoantigen Nanovaccine as Adjuvant Therapy for Colorectal Cancer/Pancreatic Cancer · Phase 1, PHASE2 · recruiting
- NCT07432633 — [18F]FPyQCP PET Imaging of Fibroblast Activation Protein in Selected Oncology Indications · Phase 1, PHASE2 · recruiting
- NCT07523919 — Functional and Respiratory Determinants of Long-Term Colorectal Cancer Outcomes · recruiting
- NCT07529301 — Functional and Respiratory Predictors of Early Postoperative Outcomes · recruiting
Other IHU Strasbourg trials
Trials by the same sponsor.
- NCT06017427 — Evaluation of Patient Satisfaction During Treatment With Dupilumab in Severe and Recurrent Nasosinusal Polyposis Despite · terminated
- NCT05515705 — First-in-human Navigation Endoscopic Ultrasound (EUS) System Clinical Study · NA · terminated
- NCT05357729 — Safety and Performance Study of the MultiSense® Ambulatory Telemonitoring System for Non-critical Patient Management · NA · completed
- NCT04899739 — Intraoperative Endoscopic Ultrasound for Pancreatic Cancer · NA · completed
- NCT05044585 — Evaluation of RDS MultiSense® in Desaturation Analysis in Healthy Volunteers · NA · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT03806244 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by IHU Strasbourg
- Last refreshed: 8 January 2024
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03806244.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing